NewsFeed Voices Science Insight Innovation
January, 2026
January 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Hema Tallman: Imagine Needing A Treatment So Rare, So Specific, That Only Plasma-derived Medicine Can Help
Hema Tallman/LinkedIn
Oct 9, 2025, 07:15

Hema Tallman: Imagine Needing A Treatment So Rare, So Specific, That Only Plasma-derived Medicine Can Help

Hema Tallman, SVP- Global Head of BioLife Plasma Services at Takeda, reposted from Takeda on LinkedIn:

”Imagine needing a treatment so rare, so specific, that only plasma-derived medicine can help.

For hundreds of thousands of people around the world, this is their reality – and their hope.

At BioLife Plasma Services, our employees are the heartbeat of this hope.

We welcome donors with care, ensure safety at every step, and help transform each donation into life-sustaining medicine.

I’m inspired by the work of Thomas – and all our employees – every day.”

Takeda shared on LinkedIn:

”Plasma is required to produce life-sustaining medicine for people with rare and serious health conditions and can’t be manufactured. It’s a precious gift that comes from generous donors. But how does this life-sustaining resource get from donor to patient?

It takes dedication, care and a whole lot of heart. Our colleagues at BioLife Plasma Services are the vital starting point in this journey – ensuring a safe and welcoming experience for every donor, and collecting the plasma that transforms lives.

This International Plasma Awareness Week (IPAW), get an inside look at the inspiring work to help maintain a reliable supply of plasma for patients.”

Read more here.

Hema Tallman: Imagine Needing A Treatment So Rare, So Specific, That Only Plasma-derived Medicine Can Help

Stay updated with Hemostasis Today.

BioLife Plasma Services Health Hema Tallman Hematology Hemostasis Hemostasis Today IPAW 2025 Medicine Plasma Donation Plasma-derived Medicine Takeda thrombosis Transfusion Medicine
NewsFeed